These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 33800412)

  • 1. Physiological Roles of ERM Proteins and Transcriptional Regulators in Supporting Membrane Expression of Efflux Transporters as Factors of Drug Resistance in Cancer.
    Ogihara T; Mizoi K; Kamioka H; Yano K
    Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33198344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NHERF1/EBP50 in Breast Cancer: Clinical Perspectives.
    Bellizzi A; Malfettone A; Cardone RA; Mangia A
    Breast Care (Basel); 2010; 5(2):86-90. PubMed ID: 21048827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Na
    Kammala AK; Bahal D; Yang C; Panettieri RA; Das R; Subramanian H
    J Immunol; 2021 May; 206(10):2301-2311. PubMed ID: 33952618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oligomerization of drug transporters: Forms, functions, and mechanisms.
    Ni C; Hong M
    Acta Pharm Sin B; 2024 May; 14(5):1924-1938. PubMed ID: 38799641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional role and regulation of permeability-glycoprotein (P-gp) in the fetal membrane during drug transportation.
    Kammala A; Benson M; Ganguly E; Richardson L; Menon R
    Am J Reprod Immunol; 2022 Feb; 87(2):e13515. PubMed ID: 34873775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the PDZ-scaffold protein NHERF1/EBP50 in cancer biology: from signaling regulation to clinical relevance.
    Vaquero J; Nguyen Ho-Bouldoires TH; Clapéron A; Fouassier L
    Oncogene; 2017 Jun; 36(22):3067-3079. PubMed ID: 28068322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NHERF1/EBP50 as a Target for Modulation of MRP Function in HepG2 Cells.
    Kawase A; Hirosoko M; Sugihara Y; Koyama Y; Fukae A; Shimada H; Iwaki M
    Pharmaceuticals (Basel); 2021 Mar; 14(3):. PubMed ID: 33800412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of NHERF1/EBP50 in cancer.
    Georgescu MM; Morales FC; Molina JR; Hayashi Y
    Curr Mol Med; 2008 Sep; 8(6):459-68. PubMed ID: 18781953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution dynamics and functional importance of NHERF1 in regulation of Mrp-2 trafficking in hepatocytes.
    Karvar S; Suda J; Zhu L; Rockey DC
    Am J Physiol Cell Physiol; 2014 Oct; 307(8):C727-37. PubMed ID: 25163515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ezrin-radixin-moesin (ERM)-binding phosphoprotein 50 organizes ERM proteins at the apical membrane of polarized epithelia.
    Morales FC; Takahashi Y; Kreimann EL; Georgescu MM
    Proc Natl Acad Sci U S A; 2004 Dec; 101(51):17705-10. PubMed ID: 15591354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The enteropathogenic Escherichia coli type III secretion system effector Map binds EBP50/NHERF1: implication for cell signalling and diarrhoea.
    Simpson N; Shaw R; Crepin VF; Mundy R; FitzGerald AJ; Cummings N; Straatman-Iwanowska A; Connerton I; Knutton S; Frankel G
    Mol Microbiol; 2006 Apr; 60(2):349-63. PubMed ID: 16573685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of breast cancer resistance protein and P-glycoprotein by ezrin, radixin and moesin in lung, intestinal and renal cancer cell lines.
    Yano K; Okabe C; Fujii K; Kato Y; Ogihara T
    J Pharm Pharmacol; 2020 Apr; 72(4):575-582. PubMed ID: 31975441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decrease in Multidrug Resistance-associated Protein 2 Activities by Knockdown of Phosphatidylinositol 4-phosphate 5-kinase in Hepatocytes and Cancer Cells.
    Kawase A; Inoue Y; Hirosoko M; Sugihara Y; Shimada H; Iwaki M
    J Pharm Pharm Sci; 2019; 22(1):576-584. PubMed ID: 31804920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radixin knockdown improves the accumulation and efficiency of methotrexate in tumor cells.
    Kawase A; Inoue Y; Nakazaki S; Koizumi E; Iwaki M
    Oncol Rep; 2019 Jul; 42(1):283-290. PubMed ID: 31115547
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.